Medicine

Contact Us School of Medicine
Level 1
Trinity Biomedical Sciences Institute
Trinity College
152-160 Pearse Street
Dublin 2

View the contact page for more contact and location information

medadmin@tcd.ie
Professor David Gallagher

Professor David Gallagher

Clinical Professor, Clinical Medicine

3531 4103759

Publications and Further Research Outputs

  • McVeigh TP, Cody N, Carroll C, Duff M, Farrell M, Bradley L, Gallagher D, McDevitt T, Green AJ., Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series., Cancer genetics, 214-215, 2017, p1-8Journal Article, 2017, DOI
  • Saya S, Killick E, Thomas S, Taylor N, Bancroft EK, Rothwell J, Benafif S, Dias A, Mikropoulos C, Pope J, Chamberlain A, Gunapala R, SIGNIFY Study Steering Committee, Izatt L, Side L, Walker L, Tomkins S, Cook J, Barwell J, Wiles V, Limb L, Eccles D, Leach MO, Shanley S, Gilbert FJ, Hanson H, Gallagher D, Rajashanker B, Whitehouse RW, Koh DM, Sohaib SA, Evans DG, Eeles RA., Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls., Familial cancer, 16, (3), 2017, p433-440Journal Article, 2017, DOI
  • O'Shea R, Clarke R, Berkley E, Giffney C, Farrell M, O'Donovan E, Gallagher DJ., Next generation sequencing is informing phenotype: a TP53 example., Familial cancer, 17, (1), 2018, p123-128Journal Article, 2018, DOI
  • Gleeson J, Gallagher D., Diagnosing Lynch Syndrome., Irish medical journal, 109, (10), 2016, p487Journal Article, 2016, DOI
  • McVeigh TP, Duff M, Carroll C, O'Shea R, Bradley L, Farrell M, Gallagher DJ, Clabby C, Green AJ., MUTYH-Associated Polyposis: The Irish Experience>., Irish medical journal, 109, (10), 2016, p485Journal Article, 2016, DOI
  • McVeigh TP, Sweeney KJ, Kerin MJ, Gallagher DJ., A qualitative analysis of the attitudes of Irish patients towards participation in genetic-based research., Ir J Med Sci, 185, (4), 2016, p825-831Journal Article, 2016, DOI
  • Gogarty DS, Farrell MP, Gallagher DJ., Genetic testing and interpretive complexity: a BRCA1 gene mutation example., Ir J Med Sci, 185, (4), 2016, p955-957Journal Article, 2016, DOI
  • Sharma S, Barry M, Gallagher DJ, Kell M, Sacchini V., An overview of triple negative breast cancer for surgical oncologists., Surgical oncology, 24, (3), 2015, p276-283Journal Article, 2015, DOI
  • Sullivan J, Kopp R, Stratton K, Manschreck C, Corines M, Rau-Murthy R, Hayes J, Lincon A, Ashraf A, Thomas T, Schrader K, Gallagher D, Hamilton R, Scher H, Lilja H, Scardino P, Eastham J, Offit K, Vijai J, Klein RJ., An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality., British journal of cancer, 113, (1), 2015, p166-172Journal Article, 2015, DOI
  • Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, Helderman-van den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramón y Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona U, Melia J, McKinley J, Mitra AV, Moynihan C, Rennert G, Suri M, Wilson P, Killick E, IMPACT Collaborators, Moss S, Eeles RA., Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study., European urology, 66, (3), 2014, p489-499Journal Article, 2014, DOI
  • Farrell MP, Hughes DJ, Drost M, Wallace AJ, Cummins RJ, Fletcher TA, Meany MA, Kay EW, de Wind N, Power DG, Andrews EJ, Green AJ, Gallagher DJ., Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity., Familial cancer, 12, (4), 2013, p741-747Journal Article, 2013, DOI
  • Gallagher DJ, Vijai J, Hamilton RJ, Ostrovnaya I, Iyer G, Garcia-Grossman IR, Kim PH, Przybylo JA, Alanee S, Riches JC, Regazzi AM, Milowsky MI, Offit K, Bajorin DF., Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host., Annals of oncology : official journal of the European Society for Medical Oncology, 24, (9), 2013, p2414-2421Journal Article, 2013, DOI
  • Bambury RM, Gallagher DJ., Prostate cancer: germline prediction for a commonly variable malignancy., BJU international, 110, (11 pt c), 2012, pE809-18Journal Article, 2012, DOI
  • Gallagher DJ, Cronin AM, Milowsky MI, Morris MJ, Bhatia J, Scardino PT, Eastham JA, Offit K, Robson ME., Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer., BJU international, 109, (5), 2012, p713-719Journal Article, 2012, DOI
  • Gallagher DJ, Al-Ahmadie H, Ostrovnaya I, Gerst SR, Regazzi A, Garcia-Grossman I, Riches J, Gounder SK, Flaherty AM, Trout A, Milowsky MI, Bajorin DF., Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response., European urology, 60, (2), 2011, p344-349Journal Article, 2011, DOI
  • Gallagher DJ, Konner JA, Bell-McGuinn KM, Bhatia J, Sabbatini P, Aghajanian CA, Offit K, Barakat RR, Spriggs DR, Kauff ND., Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity., Annals of oncology : official journal of the European Society for Medical Oncology, 22, (5), 2011, p1127-1132Journal Article, 2011, DOI
  • Tickoo SK, Milowsky MI, Dhar N, Dudas ME, Gallagher DJ, Al-Ahmadie H, Gopalan A, Fine SW, Ishill N, Bajorin DF, Reuter VE., Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications., BJU international, 107, (5), 2011, p844-849Journal Article, 2011, DOI
  • Gallagher DJ, Smith JD, Offit K, Stadler ZK., Diagnosing hereditary colorectal cancer., Clinical colorectal cancer, 9, (4), 2010, p205-211Journal Article, 2010, DOI
  • Gallagher DJ, Feifer A, Coleman JA., Genitourinary cancer predisposition syndromes., Hematology/oncology clinics of North America, 24, (5), 2010, p861-883Journal Article, 2010, DOI
  • Stadler ZK, Gallagher DJ, Thom P, Offit K., Genome-wide association studies of cancer: principles and potential utility., Oncology (Williston Park, N.Y.), 24, (7), 2010, p629-637Journal Article, 2010, DOI
  • Gallagher DJ, Kemeny N., Improving response and outcomes for patients with liver-limited metastatic colorectal cancer., Clinical colorectal cancer, 9 Suppl 1, 2010, pS36-43Journal Article, 2010, DOI
  • Gallagher DJ, Vijai J, Cronin AM, Bhatia J, Vickers AJ, Gaudet MM, Fine S, Reuter V, Scher HI, Halldén C, Dutra-Clarke A, Klein RJ, Scardino PT, Eastham JA, Lilja H, Kirchhoff T, Offit K., Susceptibility loci associated with prostate cancer progression and mortality., Clinical cancer research : an official journal of the American Association for Cancer Research, 16, (10), 2010, p2819-2832Journal Article, 2010, DOI
  • Gallagher DJ, Riches J, Bajorin DF., False elevation of human chorionic gonadotropin in a patient with testicular cancer., Nature reviews. Urology, 7, (4), 2010, p230-233Journal Article, 2010, DOI
  • Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V, Zelefsky M, Morris MJ, Scher HI, Klein RJ, Norton L, Eastham JA, Scardino PT, Robson ME, Offit K., Germline BRCA mutations denote a clinicopathologic subset of prostate cancer., Clinical cancer research : an official journal of the American Association for Cancer Research, 16, (7), 2010, p2115-2121Journal Article, 2010, DOI
  • Gallagher DJ, Milowsky MI, Gerst SR, Ishill N, Riches J, Regazzi A, Boyle MG, Trout A, Flaherty AM, Bajorin DF., Phase II study of sunitinib in patients with metastatic urothelial cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28, (8), 2010, p1373-1379Journal Article, 2010, DOI
  • Gallagher DJ, Kemeny N., Metastatic colorectal cancer: from improved survival to potential cure., Oncology, 78, (3-4), 2010, p237-248Journal Article, 2010, DOI
  • Gallagher DJ, Milowsky MI, Iasonos A, Maluf FC, Russo P, Dalbagni G, Donat MS, Boyle MG, Zheng J, Riches J, Bajorin DF., Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma., Cancer, 115, (22), 2009, p5193-5201Journal Article, 2009, DOI
  • Gallagher DJ, Kemeny NE., Colorectal hepatic metastases: adjuvant chemotherapy and survival., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, (20), 2009, pe18-9; author reply e20-1Journal Article, 2009, DOI
  • Gallagher DJ, Libby DM, Kemeny N., Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer., Clinical colorectal cancer, 8, (3), 2009, p172-174Journal Article, 2009, DOI
  • Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, Dematteo RP, D'Angelica M, Fong Y, Jarnagin WR, Allen PJ, Kemeny N., Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases., Annals of surgical oncology, 16, (7), 2009, p1844-1851Journal Article, 2009, DOI
  • Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF., Detection of circulating tumor cells in patients with urothelial cancer., Annals of oncology : official journal of the European Society for Medical Oncology, 20, (2), 2009, p305-308Journal Article, 2009, DOI
  • Gallagher D, Kemeny N., Treatment of patients with colorectal cancer: emphasis on liver metastases., Expert opinion on pharmacotherapy, 10, (1), 2009, p109-124Journal Article, 2009, DOI
  • Gallagher DJ, Milowsky MI, Bajorin DF., Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting., Cancer, 113, (6), 2008, p1284-1293Journal Article, 2008, DOI
  • Gallagher DJ, Bajorin DF., Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor., Nature clinical practice. Urology, 5, (9), 2008, p484-485Journal Article, 2008, DOI
  • Gallagher DJ, Kemeny N., Second-line management of metastatic colorectal cancer., Clinical colorectal cancer, 7, (1), 2008, p25-32Journal Article, 2008, DOI
  • Gallagher DJ, Capanu M, Raggio G, Kemeny N., Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis., Annals of oncology : official journal of the European Society for Medical Oncology, 18, (12), 2007, p1995-1999Journal Article, 2007, DOI
  • Gallagher DJ, Duffy A, McCaffrey J., Wilms' tumour in adults: a case report and review of the literature., Ir J Med Sci, 176, (1), 2007, p49-51Journal Article, 2007, DOI
  • Management of mutation negative patients in, Hereditary Gynecological Cancer: Risk, Prevention, and Management, 2008, [Gallagher DJ, Kauff N.]Book Chapter, 2008

Recognition

  • American Society of Clinical Oncology Merit Award Gastrointestinal Symposium 2010
  • . Irish Society of Medical Oncology Scholarship to MSKCC 2006
  • . ASCO/AACR/FECS Methods in Clinical Cancer Research Workshop 2007
  • American Society of Clinical Oncology Merit Award Genitourinary Symposium 2010
  • Goldstein Award MSKCC Prevention and Population Research - $50,000 2008
  • . ASCO/AACR/FECS Methods in Clinical Cancer Research Workshop (My registrar) 2019
  • American Association of Cancer Research Molecular Biology Workshop 2009
  • Broad Insititute Genetics of Complex Disorders Workshop 2008
  • . University College Dublin Scholarship to University of Pennsylvania 1998
  • American Society of Clinical Oncology Merit Award Annual Meeting 2010
  • Irish Society of Medical Oncology 2019
  • FRCPI 2019
  • PRACTICAL: The PRostate cancer AssoCiation Group To Investigate Cancer Associated aLterations in the genome 2019
  • American Society of Clinincal Oncology 2019
  • CIMBA BRCA1/2 mutation carrier consortium 2019
  • COGS: The Collaborative Ovarian, prostate, and breast Gene environment Study 2019
  • European Society of Medical Oncology 2019
  • Cancer Trials Ireland 2019
  • National Cancer Control Programme Executive Committee 2015-present
  • Reviewer for Journal of Clinical Oncology 2012-2017
  • Bobby Bastow Cancer Genetics Foundation Chair 2014-present
  • Reviewer for New England Journal of Medicine 2016